Controlled Human Infection Model (CHIM) studies

In a Controlled Human Infection Model (CHIM) study, a well-characterised strain of an infectious agent is given to carefully selected adult volunteers in order to better understand human diseases, how they spread, and

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

Liberia

With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union